250 related articles for article (PubMed ID: 11264477)
1. Molecular targets of lithium action.
Phiel CJ; Klein PS
Annu Rev Pharmacol Toxicol; 2001; 41():789-813. PubMed ID: 11264477
[TBL] [Abstract][Full Text] [Related]
2. A common mechanism of action for three mood-stabilizing drugs.
Williams RS; Cheng L; Mudge AW; Harwood AJ
Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
[TBL] [Abstract][Full Text] [Related]
3. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
[TBL] [Abstract][Full Text] [Related]
4. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
5. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
Ryves WJ; Harwood AJ
Biochem Biophys Res Commun; 2001 Jan; 280(3):720-5. PubMed ID: 11162580
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of biological effects of lithium].
Patocka J; Klár I; Strunecká A
Cesk Fysiol; 2002 Aug; 51(3):122-8. PubMed ID: 12402788
[TBL] [Abstract][Full Text] [Related]
8. Validating GSK3 as an in vivo target of lithium action.
O'Brien WT; Klein PS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1133-8. PubMed ID: 19754466
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of lithium action: state of the art, ten years later.
Shaldubina A; Agam G; Belmaker RH
Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):855-66. PubMed ID: 11383981
[TBL] [Abstract][Full Text] [Related]
11. On the functions of lithium: the mood stabilizer.
Shastry BS
Bioessays; 1997 Mar; 19(3):199-200. PubMed ID: 9103188
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of action of lithium: intracellular signaling pathways].
Zorrilla Zubilete M
Vertex; 2003; 14(51):45-52. PubMed ID: 12690409
[TBL] [Abstract][Full Text] [Related]
13. A molecular mechanism for the effect of lithium on development.
Klein PS; Melton DA
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8455-9. PubMed ID: 8710892
[TBL] [Abstract][Full Text] [Related]
14. Is competition between Li+ and Mg2+ the underlying theme in the proposed mechanisms for the pharmacological action of lithium salts in bipolar disorder?
Mota de Freitas D; Castro MM; Geraldes CF
Acc Chem Res; 2006 Apr; 39(4):283-91. PubMed ID: 16618096
[TBL] [Abstract][Full Text] [Related]
15. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
16. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
Atack JR; Broughton HB; Pollack SJ
Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
[TBL] [Abstract][Full Text] [Related]
17. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.
Williams RS; Eames M; Ryves WJ; Viggars J; Harwood AJ
EMBO J; 1999 May; 18(10):2734-45. PubMed ID: 10329620
[TBL] [Abstract][Full Text] [Related]
18. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts.
Ryves WJ; Fryer L; Dale T; Harwood AJ
Anal Biochem; 1998 Nov; 264(1):124-7. PubMed ID: 9784196
[No Abstract] [Full Text] [Related]
19. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
[TBL] [Abstract][Full Text] [Related]
20. Lithium neuroprotection: molecular mechanisms and clinical implications.
Rowe MK; Chuang DM
Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
